Vaccination Against Measles, Mumps, Rubella and Incident Inflammatory Bowel Disease in a National Cohort of Privately Insured Children
Inflammatory Bowel Diseases · 2023
DOI: 10.1093/ibd/izac176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2023. Verfasst von Catherine Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine, Obstetrics & Gynecology, and Epidemiology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Crohn Disease, Colitis, Ulcerative, Mumps, Premature Birth. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIDDK.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Infection is believed to be a potential trigger for inflammatory bowel disease (IBD). Whether vaccination against childhood infections including measles, mumps, and rubella may reduce risk of IBD is uncertain.
Methods
We conducted a retrospective cohort study using de-identified claims data from a national private payer (Optum Clinformatics Data Mart). Eligible infants were born between 2001 and 2018 and were continuously enrolled with medical and pharmacy coverage from birth for at least 2 years (n = 1 365 447). Measles, mumps, and rubella vaccination or MMR is administered beginning at 12 months of age. Cox proportional hazard regression models were used to compare time with incident disease in children by category of vaccination, after adjustment for sex, birth year, region of country, history of allergy to vaccines, and seizure history.
Results
The incidence of early pediatric IBD increased between 2001 and 2018. Ten percent (n = 141 230) of infants did not receive MMR, and 90% (n = 1 224 125) received at least 1 dose of MMR. There were 334 cases of IBD, 219 cases of Crohn’s disease, and 164 cases of ulcerative colitis. Children who had received at least 1 dose of MMR had lower risk for IBD than children who did not (hazard ratio, 0.71; 95% confidence interval, 0.59-0.85). These associations did not change after further adjustment for childhood comorbid conditions, preterm birth, or older siblings affected with IBD. Similar associations were observed for MMR with Crohn’s disease and ulcerative colitis, although these did not reach statistical significance.
Conclusion
MMR is associated with decreased risk for childhood IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Medicine, Obstetrics & Gynecology, and Epidemiology, University of Michigan, Ann Arbor, Michigan, USA.
- Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Catherine Kim
Förderung
- NIDDK NIH HHS
- NIDDK
Zitieren
APA
Kim, C., Yin, Z., Kamdar, N., & Stidham, R. (2023). Vaccination Against Measles, Mumps, Rubella and Incident Inflammatory Bowel Disease in a National Cohort of Privately Insured Children. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izac176
Vancouver
Kim C, Yin Z, Kamdar N, Stidham R. Vaccination Against Measles, Mumps, Rubella and Incident Inflammatory Bowel Disease in a National Cohort of Privately Insured Children. Inflammatory Bowel Diseases. 2023. doi:10.1093/ibd/izac176
BibTeX
@article{Kim2023,
author = {Kim, Catherine and Yin, Zhe and Kamdar, Neil and Stidham, Ryan},
title = {Vaccination Against Measles, Mumps, Rubella and Incident Inflammatory Bowel Disease in a National Cohort of Privately Insured Children},
journal = {Inflammatory Bowel Diseases},
year = {2023},
doi = {10.1093/ibd/izac176}
}
EUVIMED